Home> COVID-1912> HARMONY promoting the EHDEN Rapid Collaboration on COVID19
April 15, 2020 20:32 - x 00, 0 - 00:00
Initiated by: European Health Data & Evidence Network (EHDEN). Launch date: 15 April 2020. Deadline call: 16 May 2020.
More call details > | Download call document >
EHDEN calls for Data Partners with COVID19 data, which can assist with supporting open science research in characterizing infection and disease, as well as assessing potential clinical management and therapeutic options. The objective is to map the partners’ data to the OMOP Common Data Model in a remote and expedited way and to get evidence-based responses to some of the most urgent research questions in a matter of days rather than weeks.
Type of data sources:
HARMONY will coordinate and performe as a single federated node for all its Partners and Associated Members in the studies to come. HARMONY will collect the COVID19 data, speed up data mapping to OMOP in the HARMONY COVID19 Data Platform, and facilitate the analysis. COVID19 data will be isolated from the HARMONY hematology data.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
